Treatment of Benign enlargement of prostate

Treatment of Benign enlargement of prostate

Treatment of BEP

Lifestyle: Benign enlargement of prostate victims should reduce the rates at which they take in fluids a few hours to bedtime, reduce the amounts of alcohol and caffeine intakes and observe their voiding time schedules strictly.

Medications: There are two main types of medication that can be used to manage BPH and these include 5α-reductase inhibitors and alpha blockers.

Alpha blockers: These types of medication are the most commonly used as the first therapy in the United States and Europe. These drugs include terazosin, doxazosin, silodosin, tamsulosin and alfuzosin and are believed to

Morphology of Benign enlargement of prostate

Morphology of Benign enlargement of prostate

Morphology of BEP

Benign enlargement of prostate involves the hyperplasia of the prostatic epithelial and stromal cells which result into the development of large, slightly discrete nodules inside the periurethral area of the prostate.  When these cells are sufficiently enlarged, they force the nodules to exert pressure on the urethral canal causing slight, or at times complete urethra obstruction. This therefore may cause interference to the normal urine flow.

Risk Factors of Benign Enlargement of Prostate

Risk Factors of Benign Enlargement of Prostate

Risk Factors of Benign Enlargement of Prostate

There are various risk factors involved in the promotion of benign prostrate enlargement. The most common include:

Age: This is a major factor that influences BPH. It is believed that more than a half of men at the age of 60 are at a great risk of contracting BPH while almost 85% of men at the age of 85 are at a greater risk of developing this health condition.